Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATIC IV intravenous salbutamol loading dose in PICU severe acute asthma
2015-003551-22Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute severe asthma and wheeze comparing Intravenous salbutamol loading dose with Placebo (2 arms). Primary endpoint: Clinically relevant improvement threshold. Started Jun 2016; status: active.
02
Drugs
salbutamol
03
Conditions
acute severe asthmawheeze
Beyond the preview
Go deeper on 2015-003551-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003551-22.